Glioblastoma multiforme (GBM) is the most malignant and prevalent subtype of glioma, representing the most common primary brain tumor in adults. MRI is considered the gold standard for assessing glioblastoma. However, structural MRI alone is insufficient for accurately interpreting treatment-related… Read More
Gastrointestinal Stromal Tumors (GIST) pose unique challenges in clinical settings due to their distinct molecular features and behaviors. Imaging plays a pivotal role in evaluating diagnosis and treatment agents in GIST clinical trials. Various imaging techniques are utilized for monitoring… Read More
Sarcomas and bone tumors pose a distinctive challenge in oncology imaging, necessitating standardized protocols for precise tumor response determination in clinical trials. Multiple imaging techniques are needed to address the heterogeneity of these tumors. Imaging Endpoints applies the leading and… Read More
Hematologic cancers, originating from lymphoid and myeloid cell lines, represent about 10% of newly diagnosed malignant tumors in the United States. Among these, Multiple Myeloma survival has improved over the last decade, with the emergence of cutting-edge therapies like CAR… Read More
To arrange a conversation with our proficient medical and scientific affairs experts and discover how we can help your clinical trials with tailored imaging solutions
Featured Webinar:
Radiologic Analysis of COVID-19 Infection
June 23, 2020
